MAPT and frontotemporal dementia: Furthermore, the ability of PKA to stimulate the degradation of misfolded proteins has therapeutic promise because pharmacological agents that raise cAMP enhanced the capacity of cultured cells (13) and mouse brains (14, 16) to destroy misfolded proteins, such as mutant forms of tau that cause frontotemporal dementia.